SLNO
SOLENO THERAPEUTICS INCPrice
Daily candles with volume.
Signal stack
Where each data set points today.
- InsidersNO TRADES
No open-market buys or sells since May 18. Recent filings are awards, exercises and tax withholding.
- InstitutionsBEARISH
Q2 2026: 0 added (0 new), 26 trimmed or exited.
- EstimatesFALLING
Current-quarter EPS estimate $0.980 → $0.934 over 90 days. 0 up, 3 down in 30 days.
- Short sellersCOVERING
Short interest −32.5% to 4.41M shares. 2.3 days to cover.
Who's buying
13F· Q2 2026| Fund | Move | Value |
|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | EXIT | $0.00 |
| FMR LLC | EXIT | $0.00 |
| BANK OF AMERICA CORP /DE/ | EXIT | $0.00 |
| GOLDMAN SACHS GROUP INC | EXIT | $0.00 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | EXIT | $0.00 |
| RENAISSANCE TECHNOLOGIES LLC | EXIT | $0.00 |
| NORTHERN TRUST CORP | EXIT | $0.00 |
| MILLENNIUM MANAGEMENT LLC | EXIT | $0.00 |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
Last action Apr 2026| Date | Firm | Rating |
|---|---|---|
| Apr 17, 2026 | Wells Fargo DOWNGRADE | Equal-Weight |
| Apr 8, 2026 | HC Wainwright & Co. DOWNGRADE | Neutral |
| Apr 7, 2026 | TD Cowen DOWNGRADE | Hold |
| Apr 7, 2026 | Wolfe Research DOWNGRADE | Peer Perform |
| Apr 6, 2026 | Cantor Fitzgerald DOWNGRADE | Neutral |
| Mar 18, 2026 | Oppenheimer MAINTAIN | Outperform |
Insider ledger
Form 4| Insider | Type | Value |
|---|---|---|
Anish Bhatnagar CHIEF EXECUTIVE OFFICER May 18, 2026 | TO ISSUER | 131,400 sh |
Anish Bhatnagar CHIEF EXECUTIVE OFFICER May 18, 2026 | TO ISSUER | 115,600 sh |
Anish Bhatnagar CHIEF EXECUTIVE OFFICER May 18, 2026 | TO ISSUER | 100,000 sh |
Anish Bhatnagar CHIEF EXECUTIVE OFFICER May 18, 2026 | TO ISSUER | 200,753 sh |
Anish Bhatnagar CHIEF EXECUTIVE OFFICER May 18, 2026 | TO ISSUER | 52,709 sh |
Anish Bhatnagar CHIEF EXECUTIVE OFFICER May 18, 2026 | TO ISSUER | 73,333 sh |
Anish Bhatnagar CHIEF EXECUTIVE OFFICER May 18, 2026 | TO ISSUER | 8,473 sh |
Anish Bhatnagar CHIEF EXECUTIVE OFFICER May 18, 2026 | TO ISSUER | 35,000 sh |
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Next Q | $1.06 | $0.78–$1.55 | +0.0% | $122.9M |
| Current Q | $0.93 | $0.78–$1.26 | -0.4% | $111.8M |
| Next FY | $6.06 | $3.61–$9.92 | -3.6% | $670.5M |
| Current FY | $3.89 | $2.69–$5.55 | -1.4% | $464.3M |
Washington
Short side
FINRA· May 15, 2026SecBot reports
10 filings · 4 bullish · 3 bearish · 1 mixed · 2 neutral- BULLISH INST-CLUSTERJun 11, 2026
15 institutional investors accumulated positions in SLNO during Q3 2024, with Pictet Asset…
The cluster shows broad institutional accumulation across both passive and active managers, with notable active funds like Pictet and Tudor doubling down, while three former holders completely…
- MIXED INST-CLUSTERJun 11, 2026
Six institutional investors accumulated $883.9M in SLNO (net +$345.5M) while four reduced holdings…
The cluster is dominated by passive rebalancing (6 of 7 buyers are index/process-driven) while quant funds actively sold. This split suggests no concentrated fundamental catalyst. Monitor for an…
- BEARISH 15-12GMay 28, 2026
Soleno Therapeutics filed Form 15-12G to terminate its SEC registration under Section 12(g) and…
With Nasdaq delisting already initiated and SEC deregistration now effective, SLNO common stock will trade on OTC markets with minimal transparency. Existing shareholders face severe liquidity…
- BEARISH EFFECTMay 28, 2026
Soleno Therapeutics' shelf registration statement on Form S-3 (File No. 333-275120) was declared…
Monitor for a follow-on pricing press release or prospectus supplement. At-the-market or block offerings could weigh on SLNO shares. Given the bearish consensus and pre-revenue status, any near-term…
All SLNO filing & press-release reports (10)
- INST-CLUSTER reportJun 11, 2026
- INST-CLUSTER reportJun 11, 2026
- 15-12G reportMay 28, 2026
- EFFECT reportMay 28, 2026
- 8-K, 25-NSE reportMay 18, 2026
- 8-K reportApr 7, 2026
- 8-K reportApr 6, 2026
- CLUSTER reportMar 27, 2026
- 8-K reportFeb 26, 2026
- 8-K reportFeb 26, 2026